FDA Approves Femlyv Orally Disintegrating Birth Control Pill

Endo USA, Inc. Issues Recall of One Lot of Clonazepam Orally Disintegrating Tablets Due to Mislabeling: Incorrect Strength on Product Carton
July 16, 2024
FDA Approves Epysqli, a Biosimilar to Soliris
July 22, 2024
Endo USA, Inc. Issues Recall of One Lot of Clonazepam Orally Disintegrating Tablets Due to Mislabeling: Incorrect Strength on Product Carton
July 16, 2024
FDA Approves Epysqli, a Biosimilar to Soliris
July 22, 2024

July 22, 2024 - The U.S. Food and Drug Administration (FDA) approved Femlyv (norethindrone acetate and ethinyl estradiol), the first orally disintegrating tablet approved for the prevention of pregnancy.

  • Norethindrone acetate and ethinyl estradiol, the main ingredients in Femlyv, have been approved in the U.S. for the prevention of pregnancy as a swallowable tablet since 1968.
  • Femlyv is the first FDA-approved dissolvable birth control pill, designed for individuals who have trouble swallowing their medication.

Source: FDA

Read More at Drugs.com